Mayo Clinic Opioid Conference: Evidence, Clinical Considerations and Best Practice 2023
This course offers Live (in-person) and Livestream (virtual) attendance options
September 21-23, 2023 - The Westin Kierland - Scottsdale, Arizona
The Mayo Clinic Opioid Conference: Evidence, Clinical Considerations & Best Practice 2023 aims to highlight the shift in guidelines and public concern regarding the use of opioids in medical practice. This course provides the most up-to-date information regarding the appropriate indication for opioids in clinical practice. Topics cover the basics of opioid pharmacology and selection, evidence-based guidelines for opioid management, opioid tapering and legal considerations, as well as medical and interventional alternatives to opioids. In addition, the course covers a broad range of issues, including opioid use disorder and difficult patient conversations and guidelines to standardize the practice of opioid prescribing. This course includes lectures by experts in the field of pain medicine and opioid management as well as question and answer sessions.
This topic is important and has become a more visible public health issue. All fields within medicine that provide direct patient care are impacted, including medical, surgical and outpatient settings. All providers who prescribe (MD, DO, NP, PA, CNS) or administer (nurse, pharmacist, etc.) opioids to patients would benefit from attending this course. This course is particularly relevant for primary care providers that maintain and monitor patients on chronic opioid therapy.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
All travel and lodging expenses are the sole responsibility of the individual registrant.
Julie L. Cunningham, Pharm.D., R.Ph.
My research work relates to elucidation of the genetic basis of disease. My primary focus is the genetic basis of familial cancer, in particular, cancers of the colon, prostate, ovary, NHL and CLL, breast and pancreas. As director of the Genotyping Shared Resource, I also participate in a number of research projects including Parkinson's Disease, Vaccine Research, Addiction and Pharmacogenetics. I work closely with individuals from biostatistics, epidemiology, and the Mayo Clinic Cancer and Genomics Centers.
Benjamin Lai, M.B., B.Ch., B.A.O.
Dr. Benjamin Lai is a Consultant and Assistant Professor in the Department of Family Medicine at Mayo Clinic. He serves as the Medical Director of Mayo’s Opioid Stewardship Program. He has led efforts to expand office-based buprenorphine treatment for opioid use disorder patients at Mayo Clinic and is involved in medical student and residency training. Dr. Lai is a member of Mayo’s Controlled Substance Advisory Group. Dr. Lai is currently a Population Health Science Scholar in the Mayo Clinic Robert D. and Patricia E. Kern Center for Science and Health Care Delivery. His clinical and research interests include chronic opioid therapy for non-cancer pain and treatment for opioid use disorder using medications for opioid use disorder.
Oludare (Dare) O. Olatoye, M.D.
Dr. Olatoye received his medical degree from Johns Hopkins School of Medicine, Baltimore Maryland in 2014. He completed his residency in Anesthesiology and fellowship in pain medicine both at the Mayo Clinic School of Medicine, Rochester Minnesota. He is board-certified through the American Board of Anesthesiology in Anesthesiology and Pain Medicine. Dr. Olatoye is currently a faculty member in the Division of Pain Medicine at the Mayo Clinic Rochester Minnesota where he serves as the Medical Director of the Inpatient Pain Service. He is an active member of the Spine interventional Society, North American Neuromodulation Society and American Academy of Pain Medicine.
Mayo Clinic Faculty
In response to company inquiries, we are excited to share that the Mayo Clinic Opioid Conference: Evidence, Clinical Considerations and Best Practice 2023 has expanded its commercial support offerings to include a variety of sponsorship opportunities! Coming soon, Please see the comprehensive prospectus for full details.
If you are interested in exhibiting, please complete the Letter of Agreement.
If you have additional questions, please Contact: Joe Chanhthee